Private equity-backed PCI Pharma Services is looking for a new owner, preferably another buyout firm. The Philadelphia-based pharmaceutical outsourcing company has tapped investment bank Jefferies LLC to explore a potential sale of the company, which could value it at around $2.5 billion, according to people familiar with the matter. PCI Pharma is majority owned by Swiss asset manager Partners Group Holding AG, which acquired it in 2016 from health care-focused firm Frazier Healthcare Partners. Frazier retains a minority stake in the company. The company is expected to attract strong interest from other private-equity buyers, the people said. It expects to generate at least $150 million of earnings before interest, taxes, depreciation and amortization through the 12 months ending June 30, 2020.
Read the full article: Private Equity-Backed PCI Pharma Services Weighs a Sale //